Farzam Vaziri (F Vaziri)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Genome Wide Association

Bacillus Subtilis

Signaling Pathway

Human Immunodeficiency Virus

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Journal of cellular physiology

Antimicrobial agents and chemotherapy

BMC research notes

This page only lists publications with an associated author ORCID identifier.

Publications

Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu-Jui Yvonne Wan
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (14) (2024)
Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu-Jui Yvonne Wan
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu-Jui Yvonne Wan
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (14) (2024)
Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu-Jui Yvonne Wan
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (14) (2024)
Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu-Jui Yvonne Wan
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu-Jui Yvonne Wan
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (14) (2024)
Shima Hadifar, Abolfazl Fateh, Vahid Pourbarkhordar, Seyed Davar Siadat, Shayan Mostafaei, Farzam Vaziri
Variation in Mycobacterium tuberculosis population structure in Iran: a systemic review and meta-analysis. BMC infectious diseases 21 (1) (2021)
Mansour Kargarpour Kamakoli, Shima Hadifar, Sharareh Khanipour, Ghazaleh Farmanfarmaei, Abolfazl Fateh, Shayan Mostafaei, Seyed Davar Siadat, Farzam Vaziri
Tuberculosis under the Influence of COVID-19 Lockdowns: Lessons from Tehran, Iran. mSphere 6 (1) (2021)
Farzam Vaziri
Comment on Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles. ACS nano 14 (10) (2020)
Mansour Kargarpour Kamakoli, Sharareh Khanipour, Morteza Masoumi, Hasan Ghajavand, Ghazaleh Farmanfarmaei, Abolfazl Fateh, Seyed Davar Siadat, Farzam Vaziri
Application of MIRU-VNTR on smear slides: a shortcut for detection of polyclonal infections in tuberculosis patients. Molecular biology reports 47 (3) (2020)
Hasan Ghajavand, Mansour Kargarpour Kamakoli, Sharareh Khanipour, Shahin Pourazar Dizaji, Morteza Masoumi, Fatemeh Rahimi Jamnani, Abolfazl Fateh, Seyed Davar Siadat, Farzam Vaziri
High Prevalence of Bedaquiline Resistance in Treatment-Naive Tuberculosis Patients and Verapamil Effectiveness. Antimicrobial agents and chemotherapy 63 (3) (2019)
Behrouz Golichenari, Rahim Nosrati, Aref Farokhi-Fard, Mahdi Faal Maleki, Seyed Mohammad Gheibi Hayat, Kiarash Ghazvini, Farzam Vaziri, Seyed Mohammad Gheibihayat
Electrochemical-based biosensors for detection of Mycobacterium tuberculosis and tuberculosis biomarkers. Critical reviews in biotechnology 39 (8) (2019)
Farzam Vaziri, Thomas A Kohl, Hasan Ghajavand, Mansour Kargarpour Kamakoli, Matthias Merker, Shima Hadifar, Sharareh Khanipour, Abolfazl Fateh, Morteza Masoumi, Seyed Davar Siadat, Stefan Niemann
Genetic Diversity of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis Isolates in the Capital of Iran, Revealed by Whole-Genome Sequencing. Journal of clinical microbiology 57 (1) (2019)
Mansour Kargarpour Kamakoli, Shima Hadifar, Sharareh Khanipour, Ghazaleh Farmanfarmaei, Abolfazl Fateh, Seyed Davar Siadat, Farzam Vaziri
Comparison of MIRU-VNTR genotyping between old and fresh clinical samples in tuberculosis. Infectious diseases (London, England) 51 (9) (2019)
Shima Hadifar, Mansour Kargarpour Kamakoli, Abolfazl Fateh, Seyed Davar Siadat, Farzam Vaziri
Enhancing the differentiation of specific genotypes in Mycobacterium tuberculosis population. Scientific reports 9 (1) (2019)
Shima Hadifar, Ava Behrouzi, Abolfazl Fateh, Shohreh Khatami, Fatemeh Rahimi Jamnani, Seyed Davar Siadat, Farzam Vaziri
Comparative study of interruption of signaling pathways in lung epithelial cell by two different Mycobacterium tuberculosis lineages. Journal of cellular physiology 234 (4) (2018)
Shima Hadifar, Abolfazl Fateh, Mohammad Hadi Yousefi, Seyed Davar Siadat, Farzam Vaziri
Exosomes in tuberculosis: Still terra incognita? Journal of cellular physiology 234 (3) (2018)
Mansour Kargarpour Kamakoli, Sharareh Khanipour, Shima Hadifar, Hasan Ghajavand, Ghazaleh Farmanfarmaei, Abolfazl Fateh, Seyed Davar Siadat, Farzam Vaziri
Challenge in direct Spoligotyping of Mycobacterium tuberculosis: a problematic issue in the region with high prevalence of polyclonal infections. BMC research notes 11 (1) (2018)
Shahin Pourazar Dizaji, Alireza Taala, Morteza Masoumi, Nayereh Ebrahimzadeh, Abolfazl Fateh, Seyed Davar Siadat, Farzam Vaziri
Sub-minimum inhibitory concentration of rifampin: a potential risk factor for resuscitation of Mycobacterium tuberculosis. Antimicrobial resistance and infection control 6 (2017)
M Asnavandi, M Zargar, Farzam Vaziri, F R Jamnani, S Gharibzadeh, A Fateh, S D Siadat
EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C. Genes and immunity 18 (3) (2017)